Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 High-Risk, High-Reward Biopharma Stocks
Seeking Alpha
Tuesday, February 14, 2012 - 11:30am
tags:
Arena Pharmaceuticals, Chelsea Therapeutics, BioLineRx, Keryx, Aeterna Zentaris
BIO CEO Confab Live Blog: Day 2
TheStreet.com
Tuesday, February 14, 2012 - 11:29am
tags:
BIO CEO Conference, Pfizer, Indenix, Keryx, Delcath, Oncothyreon, Acorda Therapeutics, Human Genome Sciences, Gilead
Selling Drugs: Small Biotech Stocks With Strong Sales Growth
Seeking Alpha
Tuesday, February 14, 2012 - 11:21am
tags:
AstraZeneca, Cephalon, Dendreon, Forest Labs, Human Genome Sciences, Jazz Pharmaceuticals, Pfizer, Teva Pharmaceuticals, Spectrum Pharmaceuticals
Alexion Pharmaceuticals: A Tricky Mix Of Biotech And Pharma
Seeking Alpha
Tuesday, February 14, 2012 - 11:19am
tags:
Alexion, Gilead, Amgen, Soliris, Biogen Idec
Biogen Idec scores lung disease drug in $562.5M buyout of Stromedix
Fierce Biotech
Tuesday, February 14, 2012 - 11:18am
tags:
Stromedix, Biogen Idec, M&A, STX-100, fibrosis
Hospira's quality issues weigh on Q4 results, 2012 forecast
Fierce Pharma
Tuesday, February 14, 2012 - 11:17am
tags:
earnings, Hospira
Actelion Sees 2012 Profit Unchanged as Economic Crisis Hurts Drug Prices
Bloomberg
Tuesday, February 14, 2012 - 11:04am
tags:
guidance, Actelion
NICE sticks with 'no' for GSK's Tyverb/Roche's Herceptin
Pharma Times, UK
Tuesday, February 14, 2012 - 11:03am
tags:
NICE, UK, GSK, Roche, Herceptin, Tyverb, breast cancer
Gilead: FDA Fast Tracks Review Of HIV Drug Truvada
Morningstar
Tuesday, February 14, 2012 - 11:02am
tags:
Truvada, fast track, FDA, Gilead, HIV
The Johnson & Johnson Reputation Takes A Dive
Pharmalot
Tuesday, February 14, 2012 - 11:00am
tags:
JNJ
Surprised?! Pharma Employees Worry About Jobs
Pharmalot
Tuesday, February 14, 2012 - 11:00am
tags:
layoffs
Loss Widens at Theravance, Rev Dips
Yahoo/Zacks
Tuesday, February 14, 2012 - 10:58am
tags:
earnings, Theravance
Pfizer says its drug is best hope vs. Alzheimer's
Reuters
Tuesday, February 14, 2012 - 10:57am
tags:
Pfizer, Alzheimer's disease, BIO CEO Conference, bapineuzumab, Eli Lilly, solanezumab
Watson Pharma posts higher results, ups forecast
Reuters
Tuesday, February 14, 2012 - 10:55am
tags:
Watson Pharmaceuticals, earnings
3 Healthcare Stocks For A Healthy Return
Seeking Alpha
Tuesday, February 14, 2012 - 10:54am
tags:
Abbott Laboratories, Merck, Pfizer, Boston Scientific
DNA sequencing exposes new uses for Pfizer targeted cancer drugs
Fierce Biotech
Monday, February 13, 2012 - 8:03pm
tags:
DNA sequencing, Pfizer, cancer
Regeneron climbs after raising Eylea sales outlook
Yahoo/AP
Monday, February 13, 2012 - 8:01pm
tags:
Regeneron, Eylea
Pharmacyclics Shares Popped Again: What You Need to Know
Motley Fool
Monday, February 13, 2012 - 8:00pm
tags:
Pharmacyclics
Replacing Coumadin: A $10 Billion Opportunity
Seeking Alpha
Monday, February 13, 2012 - 7:58pm
tags:
Coumadin, Eliquis, Pfizer, Apixaban, Bristol-Myers Squibb, Xarelto, Bayer, JNJ, Pradaxa, Boehringer Ingelheim
Merck gets FDA approval of drug to treat glaucoma, ocular hypertension
Yahoo/AP
Monday, February 13, 2012 - 7:55pm
tags:
FDA, Merck, glaucoma, ocular hypertension, Zioptan

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.